{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:26:54Z","timestamp":1791098814270,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jns.2005.11.014","type":"journal-article","created":{"date-parts":[[2005,12,29]],"date-time":"2005-12-29T12:13:10Z","timestamp":1135858390000},"page":"47-54","source":"Crossref","is-referenced-by-count":77,"title":["Medication-induced exacerbation of neuropathy in Charcot Marie Tooth Disease"],"prefix":"10.1016","volume":"242","author":[{"given":"Louis H.","family":"Weimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Podwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2005.11.014_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clpt.2004.01.016","article-title":"Peripheral neuropathy in patients treated with leflunomide","volume":"75","author":"Bonnel","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jns.2005.11.014_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.58.9.1333","article-title":"Statins and risk of polyneuropathy: a case\u2013control study","volume":"58","author":"Gaist","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.11.014_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.WNL.0000043691.53710.53","article-title":"Toxic neuropathy in patients with pre-existing neuropathy","volume":"60","author":"Chaudhry","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.11.014_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/nbdi.2000.0334","article-title":"The gene for slow Wallerian degeneration (WldS) is also protective against vincristine neuropathy","volume":"8","author":"Wang","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2005.11.014_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11910-003-0043-8","article-title":"Medication-induced peripheral neuropathy","volume":"3","author":"Weimer","year":"2003","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jns.2005.11.014_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0793-289","article-title":"Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness","volume":"4","author":"Prezant","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2005.11.014_bib7","series-title":"Experimental and clinical neurotoxicology","year":"2000"},{"key":"10.1016\/j.jns.2005.11.014_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-2005-871329","article-title":"Medication and toxin-induced peripheral neuropathy","volume":"25","author":"Pratt","year":"2005","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jns.2005.11.014_bib9","series-title":"Drug-induced neurological disorders","first-page":"263","article-title":"Drug-induced peripheral neuropathies","author":"Jain","year":"2001"},{"key":"10.1016\/j.jns.2005.11.014_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00019052-200210000-00015","article-title":"Recent advances in drug-induced neuropathies","volume":"15","author":"Peltier","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jns.2005.11.014_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM197206222862523","article-title":"Vincristine neurotoxicity","volume":"286","author":"Weiden","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2005.11.014_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mpo.2950170534","article-title":"Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I","volume":"17","author":"McGuire","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08880018809031253","article-title":"Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease","volume":"5","author":"Dickerhoff","year":"1988","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/j.1326-5377.1985.tb123018.x","article-title":"Vincristine neurotoxicity in Charcot-Marie-Tooth syndrome","volume":"143","author":"Griffiths","year":"1985","journal-title":"Med J Aust"},{"key":"10.1016\/j.jns.2005.11.014_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.254.4.507b","article-title":"Vincristine neurotoxicity","volume":"254","author":"Chauncey","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2005.11.014_bib16","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1001\/jama.252.20.2862","article-title":"Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome","volume":"252","author":"Hogan-Dann","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2005.11.014_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#","article-title":"Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A","volume":"77","author":"Graf","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2005.11.014_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mpo.10105","article-title":"Vincristine neurotoxicity in the presence of hereditary neuropathy","volume":"40","author":"Trobaugh-Lotrario","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2001.03126.x","article-title":"Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity","volume":"115","author":"Naumann","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jns.2005.11.014_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1008369315240","article-title":"Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy","volume":"11","author":"Hildebrandt","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/adc.81.5.442","article-title":"Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A","volume":"81","author":"Mercuri","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jns.2005.11.014_bib22","first-page":"414","article-title":"Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease","volume":"40","author":"Uno","year":"1999","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jns.2005.11.014_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7556\/jaoa.1999.99.3.165","article-title":"Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis","volume":"99","author":"Olek","year":"1999","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.jns.2005.11.014_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1096-911X(199604)26:4<280::AID-MPO12>3.0.CO;2-J","article-title":"Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease","volume":"26","author":"Neumann","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","article-title":"Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"25","author":"Chauvenet","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7547\/87507315-93-3-229","article-title":"Charcot-Marie-Tooth disease and vincristine","volume":"93","author":"Orejana-Garcia","year":"2003","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jns.2005.11.014_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mpo.2950250212","article-title":"Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy)","volume":"25","author":"Igarashi","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib28","first-page":"709","article-title":"Charcot-Marie-Tooth disease disclosed by a treatment with vincristine in familial Hodgkin's disease","volume":"141","author":"Geny","year":"1990","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.jns.2005.11.014_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/pbc.20123","article-title":"Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor","volume":"43","author":"Schiavetti","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jns.2005.11.014_bib30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.WNL.0000032505.45389.94","article-title":"Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment","volume":"59","author":"Kalfakis","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2005.11.014_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1023\/A:1011124805315","article-title":"Uneventful administration of cisplatin to a man with X-linked Charcot-Marie-Tooth disease (CMT)","volume":"12","author":"Cowie","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ygyno.2005.01.017","article-title":"The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer","volume":"97","author":"Martino","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jns.2005.11.014_bib33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00415-002-0719-z","article-title":"Effects of antiretroviral therapy in patients with Charot-Marie-Tooth disease type 1A","volume":"249","author":"Fernandez-Torre","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2005.11.014_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/sti.78.6.462","article-title":"Peripheral neuropathy in patients with HIV infection: consider dual pathology","volume":"78","author":"Miller","year":"2002","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jns.2005.11.014_bib35","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1345\/aph.19396","article-title":"Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy","volume":"34","author":"Moudgil","year":"2000","journal-title":"Ann Pharmacother"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05004272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05004272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T21:13:45Z","timestamp":1586639625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X05004272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0022510X05004272"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.11.014","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}